RGBGX | RIRCX | RGBGX / RIRCX | |
Total Expense Ratio | 0.47 | 0.91 | 52% |
Annual Report Gross Expense Ratio | 0.47 | 0.91 | 52% |
Fund Existence | 15 years | 23 years | - |
Gain YTD | 13.537 | 16.030 | 84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 29.4B | 119B | 25% |
Annual Yield % from dividends | 2.32 | 2.63 | 88% |
Returns for 1 year | 4.74 | 9.89 | 48% |
Returns for 3 years | 46.51 | 47.72 | 97% |
Returns for 5 years | 31.53 | 53.55 | 59% |
Returns for 10 years | 60.78 | 67.72 | 90% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LABU | 87.61 | 5.12 | +6.21% |
Direxion Daily S&P Biotech Bull 3X ETF | |||
CZA | 109.05 | 1.24 | +1.15% |
Invesco Zacks Mid-Cap ETF | |||
SCDL | 38.60 | N/A | N/A |
ETRACS 2x Leveraged US Div Fctr TR ETN | |||
EMB | 95.23 | -0.03 | -0.03% |
iShares JP Morgan USD Em Mkts Bd ETF | |||
PCMM | 50.53 | -0.04 | -0.08% |
BondBloxx Private Credit CLO ETF |